EUR million
|
4–6/2025
|
4–6/2024
|
change %
|
1–6/2025
|
1–6/2024
|
change %
|
2024
|
INCOME STATEMENT
|
Revenue
|
171.3
|
174.8
|
-2.0
|
352.7
|
358.0
|
-1.5
|
704.4
|
Adjusted EBITA ¹⁾
|
14.6
|
11.4
|
27.7
|
32.6
|
26.3
|
24.0
|
55.2
|
Adjusted EBITA, % ¹⁾
|
8.5
|
6.5
|
|
9.2
|
7.3
|
|
7.8 |
Operating profit (EBIT)
|
13.0
|
9.5
|
36.1
|
29.4
|
22.2
|
32.0
|
48.5
|
Operating profit (EBIT), %
|
7.6
|
5.5
|
|
8.3
|
6.2
|
|
6.9
|
Adjusted operating profit (EBIT) ¹⁾
|
13.0
|
9.6
|
35.6
|
29.3
|
22.5
|
30.2
|
47.7
|
Adjusted operating profit (EBIT), % ¹⁾
|
7.6
|
5.5
|
|
8.3
|
6.3
|
|
6.8
|
Profit before tax (EBT)
|
11.2
|
6.7
|
66.6
|
25.9
|
16.9
|
53.1
|
38.6
|
SHARE-RELATED INFORMATION
|
Earnings per share (EPS), EUR
|
0.36
|
0.19
|
88.2
|
0.83
|
0.49
|
69.3
|
1.13
|
Equity per share, EUR
|
|
|
|
7.90
|
6.94
|
13.7
|
7.59
|
OTHER KEY FIGURES
|
Return on capital employed (ROACE), %
|
|
|
|
11.5
|
5.5
|
107.4
|
9.7
|
Return on equity (ROE), %
|
|
|
|
21.8
|
6.9
|
214.4
|
19.2
|
Equity ratio, %
|
|
|
|
28.5
|
24.3
|
16.9
|
26.8
|
Gearing, %
|
|
|
|
152.5
|
211.0
|
-27.7
|
175.5
|
Interest-bearing net debt
|
|
|
|
270.8
|
325.1
|
-16.7
|
296.6
|
Net debt/adjusted EBITDA, 12 months ¹⁾
|
|
|
|
2.5
|
3.6
|
-29.6
|
2.9
|
Interest-bearing net debt excluding IFRS 16
|
|
|
|
81.4
|
122.1
|
-33.3
|
101.8
|
Net debt/adjusted EBITDA, excluding IFRS 16, 12 months ¹⁾
|
|
|
|
1.1
|
2.0
|
-45.8
|
1.5
|
Cash flow from operating activities
|
25.2
|
27.5
|
-8.5
|
51.0
|
58.7
|
-13.2
|
100.8
|
Average number of personnel (FTE)
|
|
|
|
4,283
|
4,505
|
-4.9
|
4,416
|
Personnel at the end of the period (NOE)
|
|
|
|
6,284
|
6,721
|
-6.5
|
6,493
|
Number of practitioners
|
|
|
|
2,205
|
2,091
|
5.5
|
2,145
|
NPS, Private Healthcare Services
|
83.0
|
85.0
|
|
85.0
|
84.0
|
1.2
|
85.0
|
NPS, Public Services
|
78.0
|
79.0
|
|
79.0
|
78.0
|
1.3
|
78.0
|
eNPS (entire Group)
|
|
|
|
12.0
|
1.0
|
1,100
|
9.0
|
1) Pihlajalinna has changed the definition of adjustment items affecting comparability effective from 1 January 2025. The change simplifies the previous definition. The comparison figures have not been adjusted, as the change does not materially affect the adjusted key figures reported for the year 2024.
Pihlajalinna's definition of adjustment items affecting comparability effective from 1 January 2025:
Items affecting comparability are non-recurring and material events that are not part of normal day-to-day operations. Items affecting comparability include, among other items, costs related to business acquisitions, costs related to restructuring measures, impairment of assets, and gains and losses arising from the sale or discontinuation of business operations. Items affecting comparability only include events with an impact on profit or loss of more than EUR 0.1 million.
Pihlajalinna’s definition of adjustment items affecting comparability that was used until 31 December 2024:
Significant transactions that are not part of the normal course of business, are related to business acquisition costs (IFRS 3), are infrequently occurring events or valuation items that do not affect cash flow are treated as adjustment items affecting comparability between review periods. According to Pihlajalinna’s definition, such items include, for example, restructuring measures, impairment of assets and the remeasurement of previous assets held by subsidiaries, the costs of closing businesses and business locations, gains and losses on the sale of businesses, costs arising from operational restructuring and the integration of acquired businesses, costs related to the termination of employment relationships as well as fines and corresponding compensation payments. Pihlajalinna has also presented costs according to the IFRS Interpretations Committee’s Agenda Decision concerning cloud computing arrangements, and reversals of amortisation, as adjustment items. Cloud computing arrangements costs and reversals of amortisation according to the IFRS Interpretations Committee’s Agenda Decision has not been presented as adjustment items since 1 Jan 2024.
According to the updated definition, adjusted operating profit before amortisation of intangible assets (EBITA) for the comparison period 1 January–30 June 2024 would have been EUR 26.0 million, and adjusted EBITA for the financial year 1 January–31 December 2024 would have been EUR 54.4 million.
EBITDA adjustments during the review period amounted to EUR -3.4 (0.3) million and EUR -3,4 (0,0) million in the quarter. Adjustments to operating profit during the review period amounted to EUR 0.0 (0.3) million and EUR 0,0 (0,0) million in the quarter.